Binding of cellular proteins to the leader RNA of equine arteritis virus.

The research study explores how cellular proteins bind to the leader RNA of the equine arteritis virus (EAV). It investigated if certain cell proteins form complexes with the EAV leader RNA, with the ultimate goal of understanding how the EAV replication cycle works.

Objectives and Methodology

• The underlying objective of this research was to decipher the role of ‘leader RNA’ in the replication of the equine arteritis virus (EAV).
• The study presumed that the leader RNA of EAV, common to both genomic and subgenomic RNAs, likely carries cis-acting signals to facilitate the RNA synthesis by interacting with certain cellular or viral proteins.
• The researchers utilized gel mobility shift assays to demonstrate that proteins in Vero cell cytoplasmic extracts formed complexes with the positive and negative strands of the EAV leader RNA.
• UV-induced cross-linking assays were used to ascertain the association of proteins of varying molecular masses (between 74 to 31 kDa and 58 to 32 kDa), with the EAV leader RNA.

Key Findings

• The research discovered that some cell proteins with molecular masses ranging from 74 to 31 kDa for the positive strands, and 58 to 32 kDa for the negative strands, were detected in the UV-induced cross-linking assays with EAV leader RNA.
• Notably, intense bands were observed at the 58-52 kDa molecular weight markers for both the positive and negative strands, indicating significant binding occurring at this level.
• Observations from gel mobility shift assays using overlapping cold RNA probes to span the leader RNA positive strand showed that nucleotides 140-206 are not necessary for binding to cell proteins.
• The research implies that binding to cellular proteins, important for virus replication, can occur even in the absence of nucleotides 140-206, a discovery that can further applications in designing effective antiviral strategies.

Implications of the Research

• This study provides a clearer understanding of the replication mechanism of the EAV. The findings can form the foundation for developing therapeutic strategies against equine arteritis virus.
• Deeper understanding of protein-RNA binding patterns in virus replication may facilitate progress in designing RNA-targeted antiviral drugs or treatment mechanisms.